๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

โœ Scribed by Mark S. Soloway; Stephen W. Hardeman; David Hickey; Barbara Todd; Scott Soloway; Jane Raymond; Mohammed Moinuddin

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
725 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Inability of bone turnover marker as a s
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade
โœ Akimoto, Susumu; Furuya, Yuzo; Akakura, Koichiro; Shimazaki, Jun; Ito, Haruo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 2 views

## Background: Although clinical investigations of bone turnover markers in prostate cancer patients have been conducted, the relationships of pretreatment levels of the markers to the prognosis of patients with bone metastasis has not been fully examined. ## Methods: The serum levels of carboxy-

Evaluation of PSA, free PSA, PSMA, and t
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
โœ Murphy, Gerald P.; Troychak, Michael J.; Cobb, Oliver E.; Bowes, Victoria A.; Ke ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

BACKGROUND. Metastatic prostate cancer clinical evaluation is difficult. A revaluation of new prostate markers with regard to bone scans was performed. METHODS. Serial markers, including bone alkaline phosphatase (BAP), total alkaline phosphatase (TAP), prostate-specific antigen, total (PSA) and fre